Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diatest is a Swiss healthcare diagnostics and medical device company focused on the commercial distribution of rapid diagnostic tests, analyzers, reagents, and related accessories. The company serves physicians, hospitals, clinics, nursing homes, and pharmacies, primarily in Switzerland and Liechtenstein, and also references Europe as part of its market coverage. Its portfolio includes diabetes products, drug tests, COVID-19 antigen and antibody rapid tests, hematology and blood-analysis equipment, and other point-of-care and laboratory diagnostics. In addition to product sales, Diatest provides service support for medical technology equipment. Based on the available information, Diatest appears to operate as a commercial diagnostics supplier rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diatest.